DUBLIN--(BUSINESS WIRE)--The "Global Atrial Fibrillation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.
The atrial fibrillation devices market was valued at US$ 4,884.9 Mn in 2017, and expected to reach US$ 17,867.3 Mn by 2026 at a CAGR of 15.6% during the forecast period from 2018 to 2026.
The global atrial fibrillation devices market exhibits remunerative growth during the forecast period from 2018 to 2026 due to technological advances in atrial fibrillation devices and significant rise in prevalence of hypertension & atrial fibrillation across the world.
Based on the product type, the electrophysiology (EP) ablation catheters segment spearheaded the market in 2017 due to increasing adoption of advanced procedures such as radiofrequency catheter ablation, microwave-based catheter ablation, cryoablation, and laser-based catheter ablation. This procedure is majorly used when patients are tolerant to anti-coagulation drugs.
The cardiac monitors segment is expected to witness fastest market growth owing to the emergence of implantable cardiac monitors (ICMs) and worldwide adoption of other cardiac monitors such as holter monitors, event recorders, and mobile cardiac telemetry (MCT) to monitor heart rhythms.
Global surge in the number of hospitals and comparatively higher adoption of atrial fibrillation devices during AF procedures in hospitals are putting the hospitals segment at the dominant position.
Due to a higher presence of Afib patient population and rising adoption of advanced technologies in the U.S. and Canada, North America is likely to contribute maximum to the overall growth of atrial fibrillation devices market.
Asia Pacific is expected to exhibit lucrative CAGR over the forecast period due to growing awareness about Afib procedures, surging geriatric population, and increasing healthcare expenditure in India, China, and Japan.
Key Topics Covered
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Atrial Fibrillation Devices Market: Dynamics & Future Outlook
Chapter 4 Global Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
Chapter 5 Global Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
Chapter 6 Global Atrial Fibrillation Devices Market, by Geography, 2016-2026 (US$ Mn)
Chapter 7 Company Profiles
- AtriCure, Inc.
- Boston Scientific Corporation
- AtriCure, Inc.
- Abbott Laboratories
- Hansen Medical
- Stereotaxis, Inc.
- Biosense Webster, Inc.
- Siemens Healthineers
- Biotronik SE & Co. KG
- CardioFocus, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/hlmpqx/global_17_86?w=4